Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
Position Overview This role is pivotal in unlocking broad and fast patient access to innovative therapies. It drives high‑impact, cross‑functional initiatives and actively shapes a favorable, future‑ready healthcare environment through collaboration with key partners – including payers,
Overview Bring more to life. Are you ready to accelerate your potential and make a real difference in life sciences, diagnostics, and biotechnology? At Genedata, one of Danaher’s 15+ operating companies, our work helps scientists worldwide
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
Medical Director – Multiple Sclerosis Lead and/or support early‑stage clinical projects for multiple sclerosis, translating innovative molecules into therapies to meet unmet medical needs. Design and execute clinical development plans from Phase1 through Phase2 (proof‑of‑concept). Provide scientific
Job Overview Are you ready to accelerate your potential and make a real difference in life sciences, diagnostics and biotechnology? At Genedata, one of Danaher’s 15+ operating companies, our work saves lives – and we’re all
